Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Caliman-Fontes AT, Leal GC, Correia-Melo FS, Paixão CS, Carvalho MS, Jesus-Nunes AP, Vieira F, Magnavita G, Bandeira ID, Mello RP, Beanes G, Silva SS, Echegaray M, Carvalho LP, Machado P, Sampaio AS, Cardoso TA, Kapczinski F, Lacerda ALT, Quarantini LC.
Caliman-Fontes AT, et al. Among authors: machado p.
Trends Psychiatry Psychother. 2023;45:e20210298. doi: 10.47626/2237-6089-2021-0298. Epub 2023 Mar 7.
Trends Psychiatry Psychother. 2023.
PMID: 34904800
Free PMC article.
Clinical Trial.